Changeflow GovPing Pharma & Drug Safety Clinical Investigations: Investigators' Respons...
Routine Guidance Added Final

Clinical Investigations: Investigators' Responsibilities for Medical Devices

Favicon for www.gov.uk MHRA Guidance & Safety
Published March 30th, 2026
Detected March 30th, 2026
Email

Summary

MHRA published guidance clarifying clinical investigators' responsibilities when conducting medical device investigations in the UK. The guidance covers submission requirements, MHRA's approval process, device labeling standards, and documentation requirements. This is informational guidance without new legal obligations.

What changed

This MHRA guidance document provides comprehensive instructions for clinical investigators on meeting regulatory requirements for medical device investigations. The guidance outlines what must be included in submissions notifying MHRA of planned clinical investigations, including details on the approval process, conduct standards, device labeling requirements, and required documentation.

Clinical investigators and manufacturers conducting medical device research in the UK should review this guidance to ensure their investigation protocols and submissions align with MHRA expectations. The document serves as a practical reference for understanding regulatory requirements rather than establishing new obligations. No specific compliance deadlines or penalties are mentioned.

What to do next

  1. Review the guidance to ensure clinical investigation submissions meet MHRA requirements
  2. Verify all required documentation is prepared according to the guidance
  3. Update investigation protocols to align with MHRA labeling and conduct standards

Source document (simplified)

Guidance

Clinical investigations: investigators' responsibilities

How to make sure your clinical investigation will meet the MHRA's requirements for medical devices.

From: Medicines and Healthcare products Regulatory Agency Published 30 March 2026 Get emails about this page

Documents

Guidance for clincal investigators

HTML


Details

This guidance helps clinical investigators understand what needs to be included in a submission notifying the MHRA of a manufacturer’s plans to undertake a clinical investigation, including our approval process, conduct, labelling of devices and what documentation you need to provide.

Updates to this page

Published 30 March 2026

Sign up for emails or print this page

Get emails about this page Print this page

Named provisions

Guidance for Clinical Investigators Updates to this page

Classification

Agency
MHRA
Published
March 30th, 2026
Instrument
Guidance
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Medical device makers
Industry sector
3345 Medical Device Manufacturing 6211 Healthcare Providers
Activity scope
Medical Device Clinical Investigations Clinical Research Documentation
Geographic scope
United Kingdom GB

Taxonomy

Primary area
Medical Devices
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Healthcare Clinical Research Regulatory Compliance

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when MHRA Guidance & Safety publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.